In a recent episode of The Concord Coalition’s Facing the Future podcast, Alex Brill discussed with host, Bob Bixby, the evolving landscape of U.S. tax policy and what it signals for the federal budget—and investors.
Alex Brill moderated a discussion of how US legislators can develop successful fiscal policy, featuring Carolyn Bourdeaux and Rob Portman. This conversation was a part of the Portman Center’s 2026 Symposium “Securing Our Fiscal Future: Developing Solutions to Tackle America’s Debt and Deficit.”
Following its move in October to eliminate comparative efficacy studies for biosimilars in development, last week the FDA made further strides to streamline the biosimilar approval process in the United States.
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the next 15 drugs that will be subject to government price negotiations.
Last week, under a rarely used procedure known as a discharge motion, the House of Representatives passed a three-year extension of the enhanced Affordable Care Act (ACA) healthcare tax credit, which expired on December 31.
